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The current COVID-19 pandemic (https://www.who.
int/dg/speeches/detail/who-director-general-s-open-
ing-remarks-at-the-media-briefing-on-covid-19%2D%2
D-11-march-2020) has highlighted the importance of
science and medicine, specifically public health, in our
modern societies. Countries have taken different ap-
proaches to the pandemic.
Science and medicine will play an important role in
our way forward. Specifically, genetics and genomics will
be central in discovering variations in virus strains and
their impact on patients’ susceptibility, progression, and
outcome. Additionally, the human and zoonotic hosts’
ability to fend off the virus and the severity of disease in
patients will have genomic elements. Furthermore, the
question of long-term immunity to COVID-19 will likely
have a genomic basis which should be investigated.
Some of these genetic and genomic investigations will
undoubtedly be suitable for publication in Human Gen-
omics. We, therefore, expressly welcome submissions of
manuscripts on such subjects to the thematic series on
the “Genomics of COVID-19: molecular mechanisms
going from susceptibility to severity of the disease.”
As citizen-scientists, we also have a responsibility toward
society as citizens first and foremost but also specifically as
scientists working on improving the lives of all humans.
Political aspects of the COVID-19 pandemic and its origins
can and should not be ignored as the needs of all humans:
rich and poor, various ethnicities, rural vs. urban, different
health and political systems, etc. These aspects, if fitting
within the scope of the journal, will also be considered for
publication in this thematic series in Human Genomics.
In summary, the COVID-19 pandemic will impact all of
humanity. Basic and medical research will have an import-
ant role to play in the way forward. Genomics will make
important contributions to our understanding of origins
of and susceptibility to the disease, its progression, out-
come, possible reinfection, and much more. We look for-
ward to a lively forum in the thematic series on the
“Genomics of COVID-19: molecular mechanisms going
from susceptibility to severity of the disease” of this jour-
nal, Human Genomics, to publish and share novel and im-
portant insights into the pandemic spanning all aspects
falling within the scope of the journal at this vital time.
Abbreviation
COVID-19: Corona virus disease 2019
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